PROFESSOR Peter van Wijngaarden (pictured) has been appointed as the new Director and CEO of The Florey Institute of Neuroscience and Mental Health.
Board Chair Martin Adams praised van Wijngaarden as an outstanding leader and clinician researcher, who can help elevate The Florey's global impact.
Adams also thanked retiring Director Prof Trevor Kilpatrick for his leadership, highlighting the structural changes he oversaw.
Van Wijngaarden is Professor of Ophthalmology at the University of Melbourne and has served as Deputy Director at the Centre for Eye Research Australia.
His research interests include retinal imaging, artificial intelligence, multiple sclerosis and Alzheimer's disease.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jul 24
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jul 24
